Takeda Lebanon, part of the Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, has announced its collaboration with Barbara Nassar Association for Cancer Patient Support to alleviate the ongoing COVID-19 burden. The collaboration comes at a time when the local population in Lebanon is facing various concerns, leading to a strain on the local healthcare systems.
Rodrigo Rodriguez, General Manager of Takeda Middle East, commented: "Takeda remains committed to providing support to our communities in the Middle East. Like the rest of the world, Lebanon is also affected by the impact of the COVID-19 pandemic. As a company, we will never overlook our role and responsibility in society, serving patients, and making a positive contribution. By joining hands with relevant organizations, we hope to address some of the country's most pressing and unmet challenges to secure better health and a brighter future for patients worldwide.”
As part of Takeda's commitment to bringing innovative therapies to patients, supporting them through their disease journeys, and playing its part in helping to strengthen healthcare systems, Takeda provided support to Barbara Nassar with an in-kind donation for patients suffering from Relapsed Refractory Multiple Myeloma. Takeda Lebanon has partnered with the Barbara Nassar Association for Cancer Patient Support in the past. Takeda participated and sponsored the second Cancer Awareness Village that took place on the 28th and 29th of February 2020 at the "Forum de Beyrouth." The Cancer Awareness Village exhibition was open to the public and aimed at raising awareness about several cancer types, highlighting prevention and early detection methods, and the crucial role of support to cancer patients and their families. As Lebanon continues to witness high rates of cancer, Takeda feels that raising awareness among communities is key to reducing the mortality and morbidity rates.
Barbara Nassar has provided extensive financial and medicinal support in the past, with over 225 cancer patients hospitalized and over 795 patients receiving free medications from the organization. They have conducted multiple awareness campaigns, screenings, therapy support, and advocacy efforts in Lebanon.
Globally, Takeda continues to work towards preventing disease, training health workers, strengthening supply chains, and improving access to quality diagnosis and treatment. The company actively partners with world-class organizations and NGOs with proven track records to address global health problems in innovative and enduring ways.
